Lineage Cell Therapeutics Inc (AMEX:LCTX) has a beta value of 1.27 and has seen 0.58 million shares traded in the recent trading session. The LCTX stock price is -203.77% off its 52-week high price of $1.61 and 9.43% above the 52-week low of $0.48.
Lineage Cell Therapeutics Inc (AMEX:LCTX) trade information
Sporting 0.23% in the green today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the LCTX stock price touched $0.53 or saw a rise of 8.02%. Year-to-date, Lineage Cell Therapeutics Inc shares have moved 4.78%, while the 5-day performance has seen it change 3.21%. Over the past 30 days, the shares of Lineage Cell Therapeutics Inc (AMEX:LCTX) have changed -24.24%.
Lineage Cell Therapeutics Inc (LCTX) estimates and forecasts
The company’s shares have lost -39.55% over the past 6 months. Revenue growth from the last financial year stood is estimated to be -7.73%.
6 analysts offering their estimates for the company have set an average revenue estimate of 1.62M for the current quarter. 3 have an estimated revenue figure of 1.36M for the next ending quarter. Year-ago sales stood 2.12M and 1.44M respectively for this quarter and the next, and analysts expect sales will shrink by -23.46% for the current quarter and -7.73% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 19.25% over the past 5 years. Earnings growth for 2025 is a modest 8.33% while over the next 5 years, the company’s earnings are expected to increase by 9.14%.
LCTX Dividends
Lineage Cell Therapeutics Inc is expected to release its next earnings report in April this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Lineage Cell Therapeutics Inc (AMEX:LCTX)’s Major holders
The top two institutional holders are BROADWOOD CAPITAL INC with over 41.67 million shares worth more than $41.55 million. As of 2024-06-30, BROADWOOD CAPITAL INC held 22.0675% of shares outstanding.
The other major institutional holder is BLACKROCK INC., with the holding of over 9.56 million shares as of 2024-06-30. The firm’s total holdings are worth over $9.53 million and represent 5.2264% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF. As of Dec 31, 2024, the former fund manager holds about 2.00% shares in the company for having 4.42 shares of worth $2.33 million while later fund manager owns 3.87 shares of worth $2.04 million as of Dec 31, 2024, which makes it owner of about 1.75% of company’s outstanding stock.
